Why can’t China’s trillion-dollar generic drug market be as good as India?
In 2022, the national medical insurance negotiations will officially come to an end, and the “soul bargaining” will fail when Pfizer fails, and Paxlovid’s medical insurance will be temporarily paid until March 31, 2023. The CEO of Pfizer refused to budge, “China is the world’s second largest economy, and the new crown drug should not […]
Why can’t China’s trillion-dollar generic drug market be as good as India? Read More »